
Thanks to @RBNHSFT for recruiting our 153rd participant to @PART_Trial we are 'halfway there' ‼️🥳also a HUGE thanks to all our PART sites, teams and participants 👏😊Let's keep going 💪#PAvsRT @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol
Bryant_Lab
280 posts

@LabBryant
Professor of Urology, Academic Consultant Urologist, Prostate Cancer Research. prior CRUK/RCSEng Clinician Scientist Fellow. RT not endorsement. views my own.

Thanks to @RBNHSFT for recruiting our 153rd participant to @PART_Trial we are 'halfway there' ‼️🥳also a HUGE thanks to all our PART sites, teams and participants 👏😊Let's keep going 💪#PAvsRT @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol



New study finds focal therapy for prostate cancer is cost-effective for healthcare and better for patients news.bostonscientific.eu/focal-therapy-…









...and they're off! @NHSBartsHealth have recruited their 1st participant to the PART_Trial 🥳Congrats to all involved 👏 @LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol

Brilliant @AmCollSurgeons Congress in Chicago! So grateful to receive the international guest scholarship! Wonderful catching up with old and new friends. Brilliant to build stronger links between US UK for collaborative clinical trials. @NDSurgicalSci








We did it!! #PART has recruited its 1⃣0⃣0⃣th participant at @FrimleyHealth 🥳 a massive thank you and to all our #PARTsites for your hard work getting us there!!!👏we are a step closer to answering our important question 👍@LabBryant @SITU_Oxford @OCTRUctu @QuinteTBristol


In this review, the authors assess the current state of #focal #therapy techniques for #prostate #cancer. 🔗to Full Article: mdpi.com/3347752 📜Latest Issue: mdpi.com/2563-6499/6/3?… @SIU_urology @pcvblack @SpiessPhilippe @LysCampeauMD @DrHWoo @jteoh_hk @AmandaSJChung







